Changsha Jingyi Pharmaceutical Technology Co., Ltd. purchases Jiahang's melting point apparatus Digipol-M70

Customer: Changsha Jingyi Pharmaceutical Technology Co., Ltd.
Time: November 2022
Product Name: Automatic Melting Point Apparatus
Specification model: Digipol-M70

 Changsha Jingyi Pharmaceutical Technology Co., Ltd. (Jingyi Pharmaceutical), established in August 2010, is located in Changsha High-tech Zone, Hunan. It is a one-stop CRO service enterprise from pharmacy to clinical practice driven by innovative technology for new drug research and development. The company provides systematic solutions The mission of empowering China's pharmaceutical innovation is to be the best new drug research and development technical service provider in China.



Digipol-M70 automatic melting point apparatus combines high-precision temperature control technology and high-definition video camera technology, which not only provides users with accurate, stable and reliable test results, but also brings users an efficient and convenient test experience. The high-definition video can easily and clearly see the whole process of sample melting, and the automatic detection real-time map display is convenient for users to accurately measure the melting point and melting distance of the sample. Its innovative points for improving efficiency include: automatic integration, one-key measurement function, one-time processing of 4 samples, high-definition video instead of traditional microscope visual inspection, automatic recording of melting process, initial melting, final melting, and direct printing of data through the printer; Compliant with 21CFR Part 11, Audit Trail, Pharmacopoeia and Electronic Signature.

Thanks to Changsha Jingyi Pharmaceutical Technology Co., Ltd. for its recognition of Jiahang. Jiahang Instruments will serve you with high-quality products and after-sales services. We look forward to your company's cooperation with us again, and welcome Changsha Jingyi Medical Technology Co., Ltd. The responsible personnel put forward valuable opinions for our company.